Clinical Trial Update: Pharmaco-metabolomic Effects of Statins: METASTATINE [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pharmaco-metabolomic effects of METASTATINE in cardiovascular diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• METASTATINE (null)

Snippet

Sponsor: French Cardiology Society | Conditions: Cardiovascular Diseases | Phase 3 | Status: COMPLETED